|
1.
|
Li J, Feng Q, Kim JM, Schneiderman D,
Liston P, Li M, Vanderhyden B, Faught W, Fung MF, Senterman M,
Korneluk RG and Tsang BK: Human ovarian cancer and cisplatin
resistance: possible role of inhibitor of apoptosis proteins.
Endocrinology. 142:370–380. 2001.PubMed/NCBI
|
|
2.
|
Zwelling LA, Anderson T and Kohn KW:
DNA-protein and DNA interstrand cross-linking by cis- and
trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells
and relation to cytotoxicity. Cancer Res. 39:365–369.
1979.PubMed/NCBI
|
|
3.
|
Fichtinger-Schepman AM, van der Veer JL,
den Hartog JH, Lohman PH and Reedijk J: Adducts of the antitumor
drug cis-diamminedichloroplatinum(II) with DNA: formation,
identification, and quantitation. Biochemistry. 24:707–713. 1985.
View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Bottone MG, Soldani C, Veneroni P, Avella
D, Pisu M and Bernocchi G: Cell proliferation, apoptosis and
mitochondrial damage in rat B50 neuronal cells after cisplatin
treatment. Cell Prolif. 41:506–520. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Melendez-Zajgla J, Cruz E, Maldonado V and
Espinoza AM: Mitochondrial changes during the apoptotic process of
HeLa cells exposed to cisplatin. Biochem Mol Biol Int. 47:765–771.
1999.PubMed/NCBI
|
|
6.
|
Henkels KM and Turchi JJ:
Cisplatin-induced apoptosis proceeds by caspase-3-dependent and
-independent pathways in cisplatin-resistant and -sensitive human
ovarian cancer cell lines. Cancer Res. 59:3077–3083.
1999.PubMed/NCBI
|
|
7.
|
Miyajima A, Nakashima J, Yoshioka K,
Tachibana M, Tazaki H and Murai M: Role of reactive oxygen species
in cis-dichlorodiammineplatinum-induced cytotoxicity on bladder
cancer cells. Br J Cancer. 76:206–210. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Pugazhenthi S, Nesterova A, Sable C,
Heidenreich KA, Boxer LM, Heasley LE and Reusch JE: Akt/protein
kinase B up-regulates Bcl-2 expression through cAMP-response
element-binding protein. J Biol Chem. 275:10761–10766. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Mitsiades CS, Mitsiades N, Poulaki V,
Schlossman R, Akiyama M, Chauhan D, Hideshima T, Treon SP, Munshi
NC, Richardson PG and Anderson KC: Activation of NF-kappaB and
upregulation of intracellular anti-apoptotic proteins via the
IGF-1/Akt signaling in human multiple myeloma cells: therapeutic
implications. Oncogene. 21:5673–5683. 2002. View Article : Google Scholar
|
|
10.
|
Fraser M, Bai T and Tsang BK: Akt promotes
cisplatin resistance in human ovarian cancer cells through
inhibition of p53 phosphorylation and nuclear function. Int J
Cancer. 122:534–546. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Chipuk JE and Green DR: Dissecting
p53-dependent apoptosis. Cell Death Differ. 13:994–1002. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Green DR and Reed JC: Mitochondria and
apoptosis. Science. 281:1309–1312. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Crompton M: The mitochondrial permeability
transition pore and its role in cell death. Biochem J. 341:233–249.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Gross A, McDonnell JM and Korsmeyer SJ:
BCL-2 family members and the mitochondria in apoptosis. Genes Dev.
13:1899–1911. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Zamzami N and Kroemer G: The mitochondrion
in apoptosis: how Pandora’s box opens. Nat Rev Mol Cell Biol.
2:67–71. 2001.PubMed/NCBI
|
|
16.
|
Ku JL and Park JG: Biology of SNU cell
lines. Cancer Res Treat. 37:1–19. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Somasundaram K: Tumor suppressor p53:
regulation and function. Front Biosci. 5:D424–D437. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Shin DY, Lee WS, Lu JN, Kang MH, Ryu CH,
Kim GY, Kang HS, Shin SC and Choi YH: Induction of apoptosis in
human colon cancer HCT-116 cells by anthocyanins through
suppression of Akt and activation of p38-MAPK. Int J Oncol.
35:1499–1504. 2009.PubMed/NCBI
|
|
19.
|
Yun JW, Lee WS, Kim MJ, Lu JN, Kang MH,
Kim HG, Kim DC, Choi EJ, Choi JY, Lee YK, Ryu CH, Kim G, Choi YH,
Park OJ and Shin SC: Characterization of a profile of the
anthocyanins isolated from Vitis coignetiae Pulliat and
their anti-invasive activity on HT-29 human colon cancer cells.
Food Chem Toxicol. 48:903–909. 2010.PubMed/NCBI
|
|
20.
|
Stambolic V, MacPherson D, Sas D, Lin Y,
Snow B, Jang Y, Benchimol S and Mak TW: Regulation of PTEN
transcription by p53. Mol Cell. 8:317–325. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Feng Z: p53 regulation of the
IGF-1/AKT/mTOR pathways and the endosomal compartment. Cold Spring
Harb Perspect Biol. 2:a0010572010. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Wang WD, Li R, Chen ZT, Li DZ, Duan YZ and
Cao ZH: Cisplatin-controlled p53 gene therapy for human non-small
cell lung cancer xenografts in athymic nude mice via the CArG
elements. Cancer Sci. 96:706–712. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Antonia SJ, Mirza N, Fricke I, Chiappori
A, Thompson P, Williams N, Bepler G, Simon G, Janssen W, Lee JH,
Menander K, Chada S and Gabrilovich DI: Combination of p53 cancer
vaccine with chemotherapy in patients with extensive stage small
cell lung cancer. Clin Cancer Res. 12:878–887. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Guan YS, Liu Y, Zou Q, He Q, La Z, Yang L
and Hu Y: Adenovirus-mediated wild-type p53 gene transfer in
combination with bronchial arterial infusion for treatment of
advanced non-small-cell lung cancer, one year follow-up. J Zhejiang
Univ Sci B. 10:331–340. 2009.PubMed/NCBI
|
